Fumaric Acid

Fumaric Acid

SCHEMBL4127556

CNC.Cc1c(OCc2cccc(C#N)c2)ccc2c(CCC3CCN(CC4OCCO4)CC3)noc12.O=C(O)C=CC(=O)O

nearest known ligand 0.44

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ATP4AATP4BAXLBTKCACNA1CCACNA1DCACNA1FCACNA1SCCR5CHRM2CHRM3CPT1BCPT2DPP4DRD1DRD2EGFRERBB2ERBB4FLT3HRH1HRH3HTR1AHTR2AHTR2BHTR2CHTR4JAK1JAK2JAK3KCNH2KMT2AMAP2K1MAP2K2MEN1MLNRMPLMTORPPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PLK4PPARGRENS1PR1SLC6A2SLC6A3SLC6A4SMOTYK2atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ACHE P22303 14/20 0.44
BCHE P06276 4/20 0.44
CD274 Q9NZQ7 3/20 0.36
PDCD1 Q15116 2/20 0.36
HTR6 P50406 2/20 0.36
CHRM4 P08173 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Dimethylamine SCHEMBL4127519 0.95 ACHE (0.46) ACHEBCHECD274PDCD1HTR6
Fumaric Acid SCHEMBL4134232 0.92 ACHE (0.41) ACHEBCHECHRM4
Fumaric Acid SCHEMBL4127553 0.89 ACHE (0.43) ACHEBCHE
Fumaric Acid SCHEMBL4127558 0.89 ACHE (0.43) ACHEBCHE
Fumaric Acid SCHEMBL4130600 0.88 ACHE (0.42) ACHEBCHE
Dimethylamine SCHEMBL4126764 0.86 ACHE (0.46) ACHEBCHECD274PDCD1HTR6
Dimethylamine SCHEMBL4125115 0.86 ACHE (0.43) ACHEBCHECHRM4
Fumaric Acid SCHEMBL4113068 0.86 ACHE (0.43) ACHEBCHECHRM4
Dimethylamine SCHEMBL4126514 0.86 ACHE (0.60) ACHEBCHE
Fumaric Acid SCHEMBL4121850 0.85 ACHE (0.40) ACHEBCHECHRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090318690-A1 Benzisoxazole Compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-12-24 US disclosed
EP-2017275-A1 BENZISOXAZOLE COMPOUND Eisai R&D Management Co., Ltd. (JP) 2009-01-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090318690-A1 Benzisoxazole Compound NR1I2, NR1I3, NR0B1 ACHE 3716/4885BCHE 2215/4885CD274 4381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.